欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
ES/H/0159/003
药品名称
Vaditon Prolib 80 mg
活性成分
fluvastatin sodium salt 80.0 mg
剂型
Prolonged-release tablet
上市许可持有人
LaboratoriosVisfarm, S.L.
参考成员国 - 产品名称
Spain (ES)
互认成员国 - 产品名称
许可日期
2006/06/24
最近更新日期
2024/04/25
药物ATC编码
C10AA04 fluvastatin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common_combined_locol80_clean
Date of last change:2023/08/30
Final Product Information
|
common_combined_cranoc80_marked
Date of last change:2023/08/30
Final Product Information
|
common_combined_locol80_marked
Date of last change:2023/08/30
Final Product Information
|
common_combined_cranoc80_clean
Date of last change:2023/08/30
Final SPC
|
m 1.3.1_Lescol 20 mg Capsules_Clean_April 2017
Date of last change:2017/09/07
Final SPC
|
m 1.3.1_Lescol 20 mg Capsules_Track_April 2017
Date of last change:2017/09/07
Final SPC
|
m 1.3.1_Lescol 40 mg Capsules_Clean_April 2017
Date of last change:2017/09/07
Final SPC
|
m 1.3.1_Lescol 40 mg Capsules_Track_April 2017
Date of last change:2017/09/07
Final SPC
|
m 1.3.1_Lescol XL 80 mg Prolonged-release tablets_Clean_April 2017
Date of last change:2017/09/07
Final SPC
|
m 1.3.1_Lescol XL 80 mg Prolonged-release tablets_Track_April 2017
Date of last change:2017/09/07
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase